Trump decided to keep the government's free COVID test program running, just minutes before COVIDtests.gov was set to shut down.
The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for dupilumab to treat adults with bullous pemphigoid.
A study has found that patients with ischemic stroke and COVID-19, compared with patients without COVID-19, experience worse recovery outcomes.
A systematic review confirmed the safety and efficacy of a pulsed dye laser for the treatment of port-wine birthmarks and infantile hemangiomas.
Orismilast may be an effective and safe novel treatment option for adult patients with moderate to severe atopic dermatitis.
Compared with those without depression, participants with depression had more physical conditions at baseline and developed additional physical conditions at a faster rate. HealthDay News — ...
Mohs surgery complications risk is increased in patients who have smoked tobacco when compared with those who have never used any form of nicotine.
HealthDay News — New numbers have been released by the Texas Department of State Health Services (DSHS) in an update on the measles outbreak in Gaines County: 22 children and two adults have been ...
Injectable botulinum toxin was associated with significant efficacy and sufficient safety outcomes in treating patients with androgenetic alopecia.
Without full funding, experts warn that vital projects could be delayed or stopped altogether. HealthDay News — Federal funding for medical research has dropped by roughly $1 billion this year, ...
A total of 118 recommendations based on expert consensus were published regarding the treatment of hidradenitis suppurativa ...
Diabetic foot screening intervals could be extended beyond 1 year for patients at very low risk for diabetic foot complications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results